| Source: HalifaxProj (block) |
| Type: |
| Tumor Necrosis Factor-alpha (TNF-α) is a cytokine that plays a complex role in cancer biology. It is primarily produced by activated macrophages and is involved in systemic inflammation.
TNF-α is a pro-inflammatory cytokine that can promote inflammation, which is a known factor in cancer development. Overall, the expression of TNF-α in cancers is often linked to inflammation, tumor progression, and the tumor microenvironment. |
| Acute Myeloid Leukemia |
| 5922- | Cats, | Uncaria tomentosa acts as a potent TNF-α inhibitor through NF-κB |
| - | in-vitro, | AML, | THP1 |
| 2237- | MF, | The Effect of Pulsed Electromagnetic Field Stimulation of Live Cells on Intracellular Ca2+ Dynamics Changes Notably Involving Ion Channels |
| - | in-vitro, | AML, | KG-1 | - | in-vitro, | Nor, | HUVECs |
| 1746- | RosA, | Rosmarinic acid sensitizes cell death through suppression of TNF-α-induced NF-κB activation and ROS generation in human leukemia U937 cells |
| - | in-vitro, | AML, | U937 |
| 3009- | RosA, | Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells |
| - | in-vitro, | AML, | U937 |
| 5140- | SAS, | Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β |
| - | in-vitro, | AML, | Jurkat | - | in-vitro, | CRC, | SW-620 |
| 3429- | TQ, | Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells |
| - | in-vitro, | AML, | NA | - | in-vivo, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:2 Cells:% prod#:% Target#:309 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid